메뉴 건너뛰기




Volumn 25, Issue 3, 2006, Pages 433-442

Expression and mutation of SMAD4 in poorly differentiated carcinoma and signet-ring cell carcinoma of the colorectum

Author keywords

Colorectal cancer; Poorly differentiated adenocarcinoma; Signet ring cell carcinoma; SMAD 4; TGF beta

Indexed keywords

SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2;

EID: 33751086164     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (12)

References (34)
  • 1
    • 0020414734 scopus 로고
    • Colorectal carcinoma: Evaluation of histologic grade and factors influencing prognosis
    • Chung C.K., Zaino R.J., Stryker J.A.: Colorectal carcinoma: evaluation of histologic grade and factors influencing prognosis. J. Surg. Oncol. 21: 143-148, 1982.
    • (1982) J. Surg. Oncol. , vol.21 , pp. 143-148
    • Chung, C.K.1    Zaino, R.J.2    Stryker, J.A.3
  • 2
    • 6344245763 scopus 로고    scopus 로고
    • Clinicopathological characteristics of poorly differentiated adenocarcinoma of the colon and rectum
    • Takeuchi K., Kuwano H., Tsuzuki Y., et al.: Clinicopathological characteristics of poorly differentiated adenocarcinoma of the colon and rectum. Hepatogastroenterology. 51: 1698-1702, 2004.
    • (2004) Hepatogastroenterology , vol.51 , pp. 1698-1702
    • Takeuchi, K.1    Kuwano, H.2    Tsuzuki, Y.3
  • 4
    • 0032942805 scopus 로고    scopus 로고
    • Molecular characteristics of poorly differentiated adenocarcinoma and signet-ring-cell carcinoma of colorectum
    • Kawabata Y., Tomita N., Monden T., et al.: Molecular characteristics of poorly differentiated adenocarcinoma and signet-ring-cell carcinoma of colorectum. Int. J. Cancer. 84: 33-38, 1999.
    • (1999) Int. J. Cancer , vol.84 , pp. 33-38
    • Kawabata, Y.1    Tomita, N.2    Monden, T.3
  • 5
    • 0037145728 scopus 로고    scopus 로고
    • Poorly differentiated adenocarcinoma and mucinous carcinoma of the colon and rectum show higher rates of loss of heterozygosity and loss of E-cadherin expression due to methylation of promoter region
    • Kanazawa T., Watanabe T., Kazama S., Tada T., Koketsu S., Nagawa H.: Poorly differentiated adenocarcinoma and mucinous carcinoma of the colon and rectum show higher rates of loss of heterozygosity and loss of E-cadherin expression due to methylation of promoter region. Int. J. Cancer. 102: 225-229, 2002.
    • (2002) Int. J. Cancer. , vol.102 , pp. 225-229
    • Kanazawa, T.1    Watanabe, T.2    Kazama, S.3    Tada, T.4    Koketsu, S.5    Nagawa, H.6
  • 7
    • 0023115518 scopus 로고
    • Effects of growth factors on an intestinal epithelial cell line: Transforming growth factor beta inhibits proliferation and stimulates differentiation
    • Kurokowa M., Lynch K., Podolsky D.K.: Effects of growth factors on an intestinal epithelial cell line: transforming growth factor beta inhibits proliferation and stimulates differentiation. Biochem. Biophys Res. Commun. 142: 775-782, 1987.
    • (1987) Biochem. Biophys Res. Commun. , vol.142 , pp. 775-782
    • Kurokowa, M.1    Lynch, K.2    Podolsky, D.K.3
  • 9
    • 0030849060 scopus 로고    scopus 로고
    • Mutation analysis of the transforming growth factor-beta type II receptor in human cell lines resistant to growth inhibition by transforming growth factor-beta
    • Vincent F., Nagashima M., Takenoshita S. et al.: Mutation analysis of the transforming growth factor-beta type II receptor in human cell lines resistant to growth inhibition by transforming growth factor-beta. Oncogene. 15: 117-122, 1997.
    • (1997) Oncogene , vol.15 , pp. 117-122
    • Vincent, F.1    Nagashima, M.2    Takenoshita, S.3
  • 10
    • 0029069131 scopus 로고
    • Colon cancer cells that are not growth inhibited by TGF-beta lack functional type I and type II TGF-beta receptors
    • MacKay S.L., Yaswen L.R., Tarnuzzer R.W. et al.: Colon cancer cells that are not growth inhibited by TGF-beta lack functional type I and type II TGF-beta receptors. Ann. Surg. 221: 767-776, 1995.
    • (1995) Ann. Surg. , vol.221 , pp. 767-776
    • MacKay, S.L.1    Yaswen, L.R.2    Tarnuzzer, R.W.3
  • 11
    • 0030593038 scopus 로고    scopus 로고
    • DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1
    • Hahn S.A., Schutte M., Hoque A.T., et al.: DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science. 271: 350-353, 1996.
    • (1996) Science , vol.271 , pp. 350-353
    • Hahn, S.A.1    Schutte, M.2    Hoque, A.T.3
  • 12
    • 0032524069 scopus 로고    scopus 로고
    • Mutations in the SMAD4/DPC4 gene in juvenile polyposis
    • Howe J.R., Roth S., Ringold J.C. et al.: Mutations in the SMAD4/DPC4 gene in juvenile polyposis. Science. 1998; 280: 1086-1088.
    • (1998) Science , vol.280 , pp. 1086-1088
    • Howe, J.R.1    Roth, S.2    Ringold, J.C.3
  • 14
    • 0242490137 scopus 로고    scopus 로고
    • Restoration of SMAD4 by gene therapy reverses the invasive phenotype in pancreatic adenocarcinoma cells
    • Duda D.G., Sunamura M., Lefter et al.: Restoration of SMAD4 by gene therapy reverses the invasive phenotype in pancreatic adenocarcinoma cells. Oncogene. 22: 6857-6864, 2003.
    • (2003) Oncogene , vol.22 , pp. 6857-6864
    • Duda, D.G.1    Sunamura, M.2    Lefter3
  • 15
    • 0033814963 scopus 로고    scopus 로고
    • Loss of Dpc4 expression in colonic adenocarcinomas correlates with the presence of metastatic disease
    • Maitra A., Molberg K., Albores-Saavedra J., Lindberg G.: Loss of Dpc4 expression in colonic adenocarcinomas correlates with the presence of metastatic disease. Am. J. Pathol. 157: 1105-1111, 2000.
    • (2000) Am. J. Pathol. , vol.157 , pp. 1105-1111
    • Maitra, A.1    Molberg, K.2    Albores-Saavedra, J.3    Lindberg, G.4
  • 16
    • 0034032009 scopus 로고    scopus 로고
    • Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: Evidence that DPC4 inactivation occurs late in neoplastic progression
    • Wilentz R.E., Iacobuzio-Donahue C.A., Argani P., et al.: Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression. Cancer Res. 60: 2002-2006, 2000.
    • (2000) Cancer Res. , vol.60 , pp. 2002-2006
    • Wilentz, R.E.1    Iacobuzio-Donahue, C.A.2    Argani, P.3
  • 17
    • 0035124190 scopus 로고    scopus 로고
    • Preserved Smad4 expression in the transforming growth factor beta signaling pathway is a favorable prognostic factor in patients with advanced gastric cancer
    • Xiangming C., Natsugoe S., Takao S. et al.: Preserved Smad4 expression in the transforming growth factor beta signaling pathway is a favorable prognostic factor in patients with advanced gastric cancer. Clin. Cancer Res. 7: 277-282, 2001.
    • (2001) Clin. Cancer Res. , vol.7 , pp. 277-282
    • Xiangming, C.1    Natsugoe, S.2    Takao, S.3
  • 18
    • 0035671396 scopus 로고    scopus 로고
    • The SMAD4 protein and prognosis of pancreatic ductal adenocarcinoma
    • Tascilar M., Skinner H.G., Rosty C. et al.: The SMAD4 protein and prognosis of pancreatic ductal adenocarcinoma. Clin. Cancer Res. 7: 4115-4121, 2001.
    • (2001) Clin. Cancer Res. , vol.7 , pp. 4115-4121
    • Tascilar, M.1    Skinner, H.G.2    Rosty, C.3
  • 19
    • 20244365185 scopus 로고    scopus 로고
    • SMAD4 as a prognostic marker in colorectal cancer
    • Alazzouzi H., Alhopuro P., Salovaara R. et al.: SMAD4 as a prognostic marker in colorectal cancer. Clin. Cancer Res. 11: 2606-2611, 2005.
    • (2005) Clin. Cancer Res. , vol.11 , pp. 2606-2611
    • Alazzouzi, H.1    Alhopuro, P.2    Salovaara, R.3
  • 20
    • 0036894028 scopus 로고    scopus 로고
    • DPC4/Smad4 expression and outcome in pancreatic ductal adenocarcinoma
    • Biankin A.V., Morey A.L., Lee C.S. et al.: DPC4/Smad4 expression and outcome in pancreatic ductal adenocarcinoma. J. Clin. Oncol. 20: 4531-4542, 2002.
    • (2002) J. Clin. Oncol. , vol.20 , pp. 4531-4542
    • Biankin, A.V.1    Morey, A.L.2    Lee, C.S.3
  • 22
    • 0042666923 scopus 로고    scopus 로고
    • JTE-522, a cyclooxygenase-2 inhibitor, is an effective chemopreventive agent against rat experimental liver fibrosis
    • Yamamoto H., Kondo M., Nakamori S. et al.: JTE-522, a cyclooxygenase-2 inhibitor, is an effective chemopreventive agent against rat experimental liver fibrosis. Gastroenterology. 125: 556-571, 2003.
    • (2003) Gastroenterology , vol.125 , pp. 556-571
    • Yamamoto, H.1    Kondo, M.2    Nakamori, S.3
  • 23
    • 0036293981 scopus 로고    scopus 로고
    • Frequent loss of SMAD4/DPC4 protein in colorectal cancers
    • Salovaara R., Roth S., Loukola A. et al. Frequent loss of SMAD4/DPC4 protein in colorectal cancers. Gut. 51: 56-59, 2002.
    • (2002) Gut , vol.51 , pp. 56-59
    • Salovaara, R.1    Roth, S.2    Loukola, A.3
  • 24
    • 0033891752 scopus 로고    scopus 로고
    • Immunohistochemical labeling for dpc4 mirrors genetic status in pancreatic adenocarcinomas: A new marker of DPC4 inactivation
    • Wilentz R.E., Su G.H., Dai J.L., et al. Immunohistochemical labeling for dpc4 mirrors genetic status in pancreatic adenocarcinomas: a new marker of DPC4 inactivation. Am. J. Pathol. 156: 37-43, 2000.
    • (2000) Am. J. Pathol. , vol.156 , pp. 37-43
    • Wilentz, R.E.1    Su, G.H.2    Dai, J.L.3
  • 25
    • 10344227149 scopus 로고    scopus 로고
    • Mutations of the transforming growth factor beta type II receptor gene and microsatellite instability in gastric cancer
    • Ohue M., Tomita N., Monden T. et al.: Mutations of the transforming growth factor beta type II receptor gene and microsatellite instability in gastric cancer. Int. J. Cancer. 68: 203-206, 1996.
    • (1996) Int. J. Cancer. , vol.68 , pp. 203-206
    • Ohue, M.1    Tomita, N.2    Monden, T.3
  • 26
    • 0033587156 scopus 로고    scopus 로고
    • Higher frequency of Smad4 gene mutation in human colorectal cancer with distant metastasis
    • Miyaki M., Iijima T., Konishi M. et al.: Higher frequency of Smad4 gene mutation in human colorectal cancer with distant metastasis. Oncogene. 18: 3098-3103, 1999.
    • (1999) Oncogene , vol.18 , pp. 3098-3103
    • Miyaki, M.1    Iijima, T.2    Konishi, M.3
  • 27
    • 0348227997 scopus 로고    scopus 로고
    • Loss of DPC4 expression and its correlation with clinicopathological parameters in pancreatic carcinoma
    • Hua Z., Zhang Y.C., Hu X.M., Jia Z.G.: Loss of DPC4 expression and its correlation with clinicopathological parameters in pancreatic carcinoma. World J. Gastroenterol. 9: 2764-2767, 2003.
    • (2003) World J. Gastroenterol. , vol.9 , pp. 2764-2767
    • Hua, Z.1    Zhang, Y.C.2    Hu, X.M.3    Jia, Z.G.4
  • 29
    • 0032489508 scopus 로고    scopus 로고
    • Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Ape genes
    • Takaku K., Oshima M., Miyoshi H., Matsui M., Seldin M.F., Taketo M.M.: Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Ape genes. Cell. 92: 645-656, 1998.
    • (1998) Cell , vol.92 , pp. 645-656
    • Takaku, K.1    Oshima, M.2    Miyoshi, H.3    Matsui, M.4    Seldin, M.F.5    Taketo, M.M.6
  • 30
    • 0035859859 scopus 로고    scopus 로고
    • SMAD4 mutations in colorectal cancer probably occur before chromosomal instability, but after divergence of the microsatellite instability pathway
    • Woodford-Richens K.L., Rowan A.J., Gorman P. et al.: SMAD4 mutations in colorectal cancer probably occur before chromosomal instability, but after divergence of the microsatellite instability pathway. Proc. Natl. Acad. Sci. USA. 98: 9719-9723, 2001.
    • (2001) Proc. Natl. Acad. Sci. USA , vol.98 , pp. 9719-9723
    • Woodford-Richens, K.L.1    Rowan, A.J.2    Gorman, P.3
  • 31
    • 0029808666 scopus 로고    scopus 로고
    • Somatic alterations of the DPC4 gene in human colorectal cancers in vivo
    • Takagi Y., Kohmura H., Futamura M. et al.: Somatic alterations of the DPC4 gene in human colorectal cancers in vivo. Gastroenterology. 111: 1369-1372, 1996.
    • (1996) Gastroenterology , vol.111 , pp. 1369-1372
    • Takagi, Y.1    Kohmura, H.2    Futamura, M.3
  • 33
    • 1842479071 scopus 로고    scopus 로고
    • Defective expression of transforming growth factor beta receptor type II is associated with CpG methylated promoter in primary non-small cell lung cancer
    • Zhang H.T., Chen X.F., Wang M.H. et al.: Defective expression of transforming growth factor beta receptor type II is associated with CpG methylated promoter in primary non-small cell lung cancer. Clin. Cancer Res. 10: 2359-2367, 2004.
    • (2004) Clin. Cancer Res. , vol.10 , pp. 2359-2367
    • Zhang, H.T.1    Chen, X.F.2    Wang, M.H.3
  • 34
    • 0036875138 scopus 로고    scopus 로고
    • Altered expression of the receptor and ligand in the TGF-beta signaling pathway in diffusely infiltrating colon carcinoma
    • Nagayama S., Onodera H., Toguchida J., Imamura M.: Altered expression of the receptor and ligand in the TGF-beta signaling pathway in diffusely infiltrating colon carcinoma. Anticancer Res. 22: 3545-3554, 2002.
    • (2002) Anticancer Res. , vol.22 , pp. 3545-3554
    • Nagayama, S.1    Onodera, H.2    Toguchida, J.3    Imamura, M.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.